Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
23 January 2019 | Story Charlene Stanley | Photo Charlene Stanley
Michele Middle
Michelle Middle, CMO of Farmovs, looks forward to expanding their operations after the UFS acquired 100% shareholding in 2018.

In medical research, there are NO shortcuts.

The journey of a new medicine from lab to pharmacy shelf takes on average at least 10 years.

Michelle Middle’s journey from young medical graduate starting her first job at FARMOVS to becoming the company’s Chief Medical Officer, was more than twice that long. It was a journey that systematically and adequately equipped her to now Co-captain this flagship enterprise through its biggest challenge yet.

Michelle remembers how Farmovs started in 1974 as a research centre in the Department of Pharmacology. After graduating as medical doctor, she joined Farmovs in 1993, shortly before they moved to their current extensive facilities just south of the Sasol Library.

In 2000, international Clinical Research Organization (CRO) giant Parexel acquired a 70% shareholding, and the name changed to Farmovs-Parexel.

“Parexel really invested a lot in infrastructure and technology, bringing facilities here on par with the best in the world,” says Michelle.

Her own journey in medical research took her to George and later to the US and UK, where she held various international executive leadership positions in international companies.

When the UFS acquired a 100% shareholding in Farmovs earlier this year, she came full circle, as she returned to Bloemfontein to spearhead the expansion of patient studies in collaboration with the Faculty of Health Sciences.

“The opportunities we have here are really enormous,” says an excited Michelle.

“We are the only university in the country with this kind of infrastructure. Apart from our state-of-the-art bioanalytical lab, we also have facilities to accommodate close to 100 research participants. We now have 45 years’ experience in advanced medical research, plus established international clients. We can provide pharmaceutical companies with basically everything they need to develop new medicines.”

Another exciting development is that they are expanding their clinical-trial patient population next year from healthy individuals to people suffering from a host of chronic conditions.

“While they are part of our clinical trials, patients gain valuable insight in their own conditions. We also sometimes pick up underlying medical issues they were not even aware of,” says Michelle.

The 150 Farmovs staff members range from doctors and nurses, to technologists, medical writers, and managers. While not technically part of the university staff, they form a valued part of the Bloemfontein Campus community.

News Archive

Consideration of the future of Reitz Residence
2008-03-17

Against the background of the recent events surrounding the video produced in Reitz Residence and in terms of a resolution passed by the Council of the University of the Free State (UFS) on 7 March 2008, the Rector and the Management of the UFS are at present considering the future of the Reitz Residence on the main campus of the University.

According to the Council resolution, this may include the possible closure of the residence and its conversion into either a new residence or accommodation facility or a different type of facility for use by the University. The guideline by Council is that it should become a beacon of transformation, hope and liberation.

The substantive issues that will be considered in taking the above-mentioned decision include, among others: the necessity of utilising the residence for other needs; the promotion of transformation and diversity in residences and on the campus; the educational and career interests of future residents; safety and security on the campus; and the effective functioning and strategic objectives of the UFS, including the place and profile of the UFS in the national and international university context, the UFS’s co-operation with other universities, organisations and experts, the UFS’s community engagement, and strategic partnerships with the business sector.

No such decision will be taken before the persons who will be affected directly by such a decision have been afforded a reasonable opportunity to make submissions and proposals for consideration by the Management. These direct stakeholders, in law, have been identified as:

  • students residing in Reitz at present;
  • parents of students residing in Reitz at present; and
  • present staff of Reitz.

In addition, any stakeholder or group of stakeholders are invited to make proposals by way of written submissions on the basis of the above-mentioned before or on 14 April 2008.

The University gives its assurance that whatever is ultimately decided, reasonable notice will be given to all the above-mentioned direct stakeholders and that the implementation will take place in a fair and reasonable manner to avoid causing unnecessary disruption for students, parents and staff.

Please send written submissions to:
The Vice-Rector: Student Affairs
Reitz issue
University of the Free State
PO Box 339
Bloemfontein 9300

Fax number: 051 444-0740
Email address: voorstelle@ufs.ac.za  

Prof. FCvN Fourie
Rector and Vice-Chancellor

Media Release
Issued by: Mr Anton Fisher
Director: Strategic Communication
Tel: 051 401 3422
Cell: 072 207 8334
E-mail: fishera.stg@ufs.ac.za  
17 March 2008

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept